LifeMD Shares Shoot Higher On Robust Q1 Telemedicine Revenues, FY Revenue Outlook Exceeding Consensus

  • LifeMD Inc LFMD reported Q1 adjusted EPS loss of $(0.38) better than the consensus loss of $(0.67).
  • Revenue increased 323% Y/Y to a record $18.2 million in line with the consensus, primarily driven by a 349% increase in telemedicine product revenues.
  • Total Telehealth Orders increased 373% Y/Y to 164 thousand.
  • The company's LegalSimpli subsidiary, a PDF software-as-a-service, contributed $4.9 million in net sales, up 264% Y/Y.
  • The gross margin expanded to 82% from 69% last year, attributable to lower product costs, growth of the prescription business, and inventory management.
  • Adjusted EBITDA loss of $8.9 million compared to a loss of $556 thousand in the year-ago quarter.
  • Cash balance for the quarter totaled $13.4 million.
  • Guidance: For FY21, the company is raising its revenue guidance to $90 million and $100 million from its previous guidance of $85 and $95 million, exceeding the consensus of $87.8 million
  • Price Action: LFMD shares are up 14.9% at 7.48 during the premarket session on the last check Friday.
Loading...
Loading...
LFMD Logo
LFMDLifeMD Inc
$12.885.92%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
96.03
Growth
17.44
Quality
Not Available
Value
27.71
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...